Show simple item record

dc.contributor.authorArrigan, M T
dc.contributor.authorKilleen, R P
dc.contributor.authorDodd, J D
dc.contributor.authorTorreggiani, W C
dc.date.accessioned2012-02-01T10:48:18Z
dc.date.available2012-02-01T10:48:18Z
dc.date.issued2012-02-01T10:48:18Z
dc.identifier.citationClin Radiol. 2011 Mar;66(3):203-23. Epub 2011 Jan 8.en_GB
dc.identifier.issn1365-229X (Electronic)en_GB
dc.identifier.issn0009-9260 (Linking)en_GB
dc.identifier.pmid21295200en_GB
dc.identifier.doi10.1016/j.crad.2010.10.011en_GB
dc.identifier.urihttp://hdl.handle.net/10147/207859
dc.description.abstractSudden athlete death (SAD) is a widely publicized and increasingly reported phenomenon. For many, the athlete population epitomize human physical endeavour and achievement and their unexpected death comes with a significant emotional impact on the public. Sudden deaths within this group are often without prior warning. Preceding symptoms of exertional syncope and chest pain do, however, occur and warrant investigation. Similarly, a positive family history of sudden death in a young person or a known family history of a condition associated with SAD necessitates further tests. Screening programmes aimed at detecting those at risk individuals also exist with the aim of reducing fatalities. In this paper we review the topic of SAD and discuss the epidemiology, aetiology, and clinical presentations. We then proceed to discuss each underlying cause, in turn discussing the pathophysiology of each condition. This is followed by a discussion of useful imaging methods with an emphasis on cardiac magnetic resonance and cardiac computed tomography and how these address the various issues raised by the pathophysiology of each entity. We conclude by proposing imaging algorithms for the investigation of patients considered at risk for these conditions and discuss the various issues raised in screening.
dc.language.isoengen_GB
dc.subject.meshAdolescenten_GB
dc.subject.meshAdulten_GB
dc.subject.meshAlgorithmsen_GB
dc.subject.meshAortic Valve Stenosis/diagnosis/etiologyen_GB
dc.subject.meshArrhythmogenic Right Ventricular Dysplasia/diagnosis/etiologyen_GB
dc.subject.mesh*Athletesen_GB
dc.subject.meshCardiomyopathy, Dilated/diagnosis/etiologyen_GB
dc.subject.meshChest Pain/epidemiology/etiology/mortalityen_GB
dc.subject.meshCoronary Artery Disease/diagnosis/etiologyen_GB
dc.subject.meshDeath, Sudden, Cardiac/epidemiology/*etiology/prevention & controlen_GB
dc.subject.meshDiagnostic Imaging/*methodsen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMass Screeningen_GB
dc.subject.meshMitral Valve Prolapse/diagnosisen_GB
dc.subject.meshMyocarditis/diagnosis/etiologyen_GB
dc.subject.meshSarcoidosis/diagnosis/etiologyen_GB
dc.subject.meshSyncope/*complications/epidemiology/mortalityen_GB
dc.subject.meshYoung Adulten_GB
dc.titleImaging spectrum of sudden athlete cardiac death.en_GB
dc.contributor.departmentDepartment of Radiology, Adelaide and Meath Hospital incorporating the National, Children's Hospital, Dublin, Ireland. martinarrigan@gmail.comen_GB
dc.identifier.journalClinical radiologyen_GB
dc.description.provinceLeinster
html.description.abstractSudden athlete death (SAD) is a widely publicized and increasingly reported phenomenon. For many, the athlete population epitomize human physical endeavour and achievement and their unexpected death comes with a significant emotional impact on the public. Sudden deaths within this group are often without prior warning. Preceding symptoms of exertional syncope and chest pain do, however, occur and warrant investigation. Similarly, a positive family history of sudden death in a young person or a known family history of a condition associated with SAD necessitates further tests. Screening programmes aimed at detecting those at risk individuals also exist with the aim of reducing fatalities. In this paper we review the topic of SAD and discuss the epidemiology, aetiology, and clinical presentations. We then proceed to discuss each underlying cause, in turn discussing the pathophysiology of each condition. This is followed by a discussion of useful imaging methods with an emphasis on cardiac magnetic resonance and cardiac computed tomography and how these address the various issues raised by the pathophysiology of each entity. We conclude by proposing imaging algorithms for the investigation of patients considered at risk for these conditions and discuss the various issues raised in screening.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record